Morningstar10d
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
Trading commencing on the OTC Markets on March 5 ... determined to delist the Company’s common stock from the Nasdaq Global Market after the close of trading on March 4, 2025, solely due ...
Stockhouse9d
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
Trading commencing on the OTC Markets on March 5, 2025 ... s common stock from the Nasdaq Global Market after the close of trading on March 4, 2025, solely due to the Company’s ...